Format

Send to

Choose Destination
J Clin Invest. 2019 May 1;129(5):1808-1817. doi: 10.1172/JCI125797. Epub 2019 May 1.

The gut microbiota and graft-versus-host disease.

Abstract

Graft-versus-host disease (GvHD) is a common complication of hematopoietic cell transplantation that negatively impacts quality of life in recipients and can be fatal. Animal experiments and human studies provide compelling evidence that the gut microbiota is associated with risk of GvHD, but the nature of this relationship remains unclear. If the gut microbiota is a driver of GvHD pathogenesis, then manipulation of the gut microbiota offers one promising avenue for preventing or treating this common condition, and antibiotic stewardship efforts in transplantation may help preserve the indigenous microbiota and modulate immune responses to benefit the host.

PMID:
31042160
PMCID:
PMC6486325
[Available on 2020-05-01]
DOI:
10.1172/JCI125797
Free full text

Supplemental Content

Full text links

Icon for American Society for Clinical Investigation
Loading ...
Support Center